Status:
UNKNOWN
A Pilot Study for Adaptation of Neospot Device for Health Care at Primary Health Facilities in Kenya
Lead Sponsor:
Neopenda, PBC
Collaborating Sponsors:
Amref Health Africa
Conditions:
Morbidity
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Neospot device is a 5-in-1 wearable vital signs monitor designed to measure temperature, blood pressure, pulse rate (PR), respiratory rate (RR) and blood oxygen saturation (SPO2). We propose to study ...
Detailed Description
This study intends to investigate the experiences of both nurses and patients in the use of a specific brand of such a device known as the 'neospot' device in various sub county, health centres in Ken...
Eligibility Criteria
Inclusion
- Participants between 18 and 70 years of age
- In stable condition
- Willing to give consent to participate in the study
Exclusion
- Very ill and unstable patients who need emergency care
- Patients with medical conditions that are characterized by rapid changes in vital signs such as thyroid disorders
- Patients who have skin lesions on the forehead where the device is to be fixed
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
159 Patients enrolled
Trial Details
Trial ID
NCT06132633
Start Date
December 1 2023
End Date
April 1 2024
Last Update
November 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Langata, Kianda 42 and Matasia Health Centre
Nairobi, Kenya, 00100